http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm403122.htm
Here's what I read some time ago.
@mountainman
I do think the quote above stinks of a sales pitch and, more seriously, a lack of knowledge and understanding of diabetes. Period (as they say in the USA).
The bottom line for me is that this drug is purely a faster acting fast acting insulin.
What any T1 diabetic will tell you is quite simple. We cannot produce insulin thus we inject it. We need to know how the food we are eating effects our BG levels. We need to know how much insulin is required to counteract this. We need to know when to take the insulin to have the maximum effect.
All the sales pitches in the world will not change the facts above and they are grossly over-simplified.
Yes, the product sounds great. Will it change my daily life as a T1 diabetic? I don’t think so. If I eat a carb heavy meal I can’t just say, ok 4U inhaled, sorted. I’d hypo 20mins later. I would need to wait until the delayed spike was due and then take it. Yes, over time you would learn but your comments are far too simplistic and frankly dangerous regarding hypos.
“A Review of Inhaled Technosphere Insulin”, Neumiller, Campbell & Wood found a greater incidence of hypoglycaemia in the trials of T2 diabetics using Technosphere compared to regular brand fast acting insulin. Not just in the initial 6 months, it increased in time over a four year study.
What people who don’t live in the diabetic world can’t understand is the complexity of the condition and how many factors come into play. This is not replicating the pancreas. If you want to make that claim then you need a product which can be in the system and kick in when BG level rises just as the pancreas does. There is one in production if you look for it.
I said earlier I had 50% optimism for this product, I think there could be great benefits for something which acts so quickly, I really do. However, I think your comments are seriously flawed.